Literature DB >> 2968833

Ocular lesions in chickens inoculated with Escherichia coli.

K Nakamura1, F Abe.   

Abstract

Specific-pathogen-free chickens (two, four and ten weeks of age) which were inoculated via the air sac with Escherichia coli developed ocular lesions. Histologically, the main ocular lesions consisted of hyphema, hemorrhages of the iris, hypopyon, keratitis and uveitis. Hyphema was associated with hemorrhages of the iris, and hypopyon with keratitis and uveitis. Cyclophosphamide treatment enhanced the incidence and severity of hyphema and hemorrhages of the iris in the chickens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2968833      PMCID: PMC1255379     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  5 in total

1.  Blindness in chicks associated with salmonellosis.

Authors:  W M EVANS; D W BRUNER; M C PECKHAM
Journal:  Cornell Vet       Date:  1955-04

2.  Escherichia coli serotypes isolated from chickens infected with Mycoplasma gallisepticum.

Authors:  S Sato; I Nonomura; K Hashimoto
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1972

3.  [Pathomorphological changes in the eyes of turkeys in Salmonella arizonae infections].

Authors:  M Lávicka; A Matusů
Journal:  Vet Med (Praha)       Date:  1982       Impact factor: 0.558

4.  Natural and experimental Salmonella arizonae 18:z4,z32 (Ar. 7:1,7,8) infection in broilers. Bacteriological and histopathological survey of eye and brain lesions.

Authors:  E N Silva; O Hipolito; R Grecchi
Journal:  Avian Dis       Date:  1980 Jul-Sep       Impact factor: 1.577

5.  Ophthalmia in turkeys infected with Pasteurella multocida.

Authors:  L D Olson
Journal:  Avian Dis       Date:  1981 Apr-Jun       Impact factor: 1.577

  5 in total
  1 in total

1.  The effect of sodium chloride extract and commercial lipopolysaccharides of Escherichia coli and Salmonella typhimurium on chickens.

Authors:  K Nakamura; F Abe
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.